Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluating a New Phosphate-Containing Fluid for Blood Purification (CRRT)
NCT07550894Phase 3Not yet recruiting
- Sponsor
- Sun Yat-sen University
- Start
- May 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute kidney injury (AKI) and sepsis (2 arms), sponsored by Sun Yat-sen University. Primary endpoints: Change in Serum Creatinine at 72 Hours and Incidence of Hypophosphatemia Within 72 Hours. Planned start May 2026; status: not yet recruiting.
02
Conditions
acute kidney injury (AKI)sepsis
Beyond the preview
Go deeper on NCT07550894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07550894.